from sept 25 to 27, 2024


We are delighted to announce the brand-new European meeting dedicated to neuroimaging of neurodegenerative diseases: EU-MIND (EUropean Meeting on Imaging of Neurodegenerative Diseases). This will be the first European congress of its kind, bringing together brilliant minds from all over Europe and beyond to forge innovative collaborations in support of advances in Alzheimer’s disease research.

The inaugural edition of a biennial series will take place from September 25 to 27, 2024, in Caen, Normandy, France.

Why such a congress?

  • Unprecedented focus: EU-MIND is dedicated exclusively to neuroimaging in neurodegenerative diseases, bringing together the European community working on this vital subject.
  • Networking and collaboration: Get in touch with top-level researchers, clinicians and experts in a dynamic, interdisciplinary environment.
  • Scientific excellence: EU-MIND aims to be at the forefront of research in the field of neuroimaging and neurodegenerative diseases, including Alzheimer’s disease.
  • Advancing research: by bringing together leading experts in the field to discuss and collaborate on current topics and issues, EU-MIND hope to provide the ideal breeding ground for major advances in the understanding, prevention and treatment of neurodegenerative diseases.
  • Supporting and promoting young researchers in/from Europe


Initiated by the Neuropresage team of the Inserm Caen U1237 unit and organized by the EU-MIND Scientific Committee, the first edition of EU-MIND is supported by the Fondation Alzheimer.


Origins of the congress

The inception of EU-MIND was ignited by the collective vision of Gael Chetelat, Julie Gonneaud, and Robin de Flores from the Neuropresage team (Caen, France). Recognizing a conspicuous void within the European neuroimaging community, they discerned the absence of a dedicated platform for experts in neurodegenerative diseases. Motivated by this observation, they felt a compelling need to bridge this gap and establish an exclusive forum where researchers, clinicians, and engineers across Europe could convene, exchange insights, and foster collaborations. EU-MIND emerged organically as the response to this imperative, paving the way towards a more interconnected and impactful European research landscape in neuroimaging of neurodegenerative diseases.

What is the role of the Fondation Alzheimer ?

The Fondation Alzheimer is a private funding organization dedicated to supporting Alzheimer’s research, innovation, and prevention efforts at the national, European, and international levels. One of its primary objectives is to address gaps in high-priority research areas.

Given that neuroimaging in neurodegenerative diseases offers significant advancements in understanding pathophysiology, diagnosing, and treating Alzheimer’s disease, the Fondation Alzheimer plays a pivotal role in shaping in the EU-MIND initiative.

The foundation actively contributes its expertise by participating in strategic vision and serving on the Scientific Committee. Moreover, it provides substantial financial support to cover conference expenses, travel grants, and other necessities.

The Fondation Alzheimer takes pride in being an early founder of EU-MIND, ensuring its sustainability, attractiveness, and excellence.



This website uses cookies to ensure audience measurement, as well as sharing or redirection to social networks. (Know more)